Andrew Denver

Biography

 Mr. Denver has extensive expertise that is relevant to the Company, including in assisting the commercialisation of several technology companies.  Mr. Denver has a wide ranging knowledge of the life sciences industry of which our Company is a part, risk assessment, financial reporting experience and general management, which are important in the success of our business.  Mr. Denver has served as the interim Chief Executive Officer of the Company from September 2010 to May 2011 and from March 2016. He was a director of the Company from December 2002 to August 2017 and Chairman from September 2005 to August 2017. Between 2002 and 2005, Mr. Denver was President of Pall Asia, a subsidiary of Pall Corporation after the acquisition by Pall Corporation of US Filter’s Filtration and Separations business, where he was also President.  Pall Corporation is a technology based filtration, separation and purification multinational company.  Mr. Denver is a director and founder of PFM Cornerstone Ltd, a company which helps Australian technology businesses, which are predominately in the life sciences industry, commercialize their technologies.  Mr. Denver is a non-executive director of Vaxxas, Inc., SpeeDx Pty Ltd and Cochlear Ltd, all of which are life sciences companies, and until September 2010 and October 2008, was also a non-executive director of CathRx Ltd and Anzon Australia Ltd, respectively.  Mr. Denver graduated from the University of Manchester with a Bachelor of Science Degree (Honors) in Chemistry and achieved a distinction in his M.B.A. at the Harvard Business School and is a Fellow of the Australian Institute of Company Directors.

Research Interest

 Chemical Sciences